Ruth Duncan

Materials Science · Physical Sciences

77h-index28.0kcitations275works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Nanoparticle-Based Drug Delivery(91), RNA Interference and Gene Delivery(56), Advanced Polymer Synthesis and Characterization(27), Dendrimers and Hyperbranched Polymers(26), Cancer Treatment and Pharmacology(26)

Publications275 total

In Memoriam: Stephen H. Jenkins (1946 – 2024)
Journal of Mammalogy·2025Open Access
Nanomedicine(s) under the Microscope *
2020· 6 cited
Author response for "Fear Of Hypoglycemia In Children With Type 1 Diabetes And Their Parents: Effect Of Pump Therapy And Continuous Glucose Monitoring With Option Of Low Glucose Suspend In The Cgm Time Trial"
2020
Author response for "Fear Of Hypoglycemia In Children With Type 1 Diabetes And Their Parents: Effect Of Pump Therapy And Continuous Glucose Monitoring With Option Of Low Glucose Suspend In The Cgm Time Trial"
2020
Polymer therapeutics at a crossroads? Finding the path for improved translation in the twenty-first century
Journal of drug targeting·2017· 54 cited
Highly cited research articles in Journal of Controlled Release: Commentaries and perspectives by authors
Journal of Controlled Release·2014· 787 cited
6. Reflections on the emergence of new thematic research: Development of electrospun nanostructured DNA delivery scaffolds
Journal of Controlled Release·2014· 1 cited
15. Vitamin E TPGS based nanoparticles of biodegradable polymers for controlled release of anticancer drugs
Journal of Controlled Release·2014· 5 cited
4. Poly(NIPAAm) revisited—It has been 28years since it was first proposed for use as a biomaterial
Journal of Controlled Release·2014· 1 cited
11. Biodegradable electrospun fibers as drug delivery system for local cancer treatment: A rugged path to the bright future
Journal of Controlled Release·2014
Highly cited research articles in Journal of Controlled Release: Commentaries and perspectives by authors
Journal of Controlled Release·2014
7. Ethosomes—An innovative carrier for enhanced delivery into and across the skin
Journal of Controlled Release·2014
22. The impact of “Development of the polymer micelles carrier system for doxorubicin” on the nanomedicine realm
Journal of Controlled Release·2014· 6 cited
2. Commentary on dendrimers: Why dendrimers?
Journal of Controlled Release·2014· 3 cited
23. From stealthy, controlled release polymersomes to cylinder-shaped ‘filomicelles’ for imaging and delivery
Journal of Controlled Release·2014
19. Targeted nanoparticles for smarter cancer therapy
Journal of Controlled Release·2014
13. From tissue engineering to therapeutic cancer vaccines
Journal of Controlled Release·2014
Polymer therapeutics: Top 10 selling pharmaceuticals — What next?
Journal of Controlled Release·2014· 159 cited
Myofascial Release
Human Kinetics eBooks·2014· 7 cited
Validation of tumour models for use in anticancer nanomedicine evaluation: the EPR effect and cathepsin B-mediated drug release rate
Cancer Chemotherapy and Pharmacology·2013· 61 citedOpen Access
page 1 of 14Next →

Frequent Co-authors

J. Strohalm(6), Marı́a J. Vicent(6), Jindřich Kopeček(6), Karel Ulbrich(5), N Malik(4), Leonard W. Seymour(4), Evagoras G. Evagorou(3), John B. Lloyd(3), Pavla Rejmanová(3), Ruedeekorn Wiwattanapatapee(2), Rogério Gaspar(2), Hiroshi Maeda(2), M. Brereton(2), Elisabetta Gianasi(2), Steve Brocchini(2), Begoña Carreño-Gómez(2), Francesca Greco(2), Robert I. Nicholson(2), Ronit Satchi(2), Isabella C. Hume(2)